All Relations between Alzheimer Disease and microtubule-associated protein tau

Publication Sentence Publish Date Extraction Date Species
Lian-Feng Lin, Huan-Min Lu. Screening of treatment targets for Alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation. Neuroscience bulletin. vol 27. issue 1. 2011-05-02. PMID:21270904. screening of treatment targets for alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation. 2011-05-02 2023-08-12 Not clear
Lian-Feng Lin, Huan-Min Lu. Screening of treatment targets for Alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation. Neuroscience bulletin. vol 27. issue 1. 2011-05-02. PMID:21270904. β-amyloid (aβ) over-expression and tau hyperphosphorylation are considered to be the central events in the pathogenesis of alzheimer's disease (ad). 2011-05-02 2023-08-12 Not clear
Xiao-Ping Hong, Cai-Xia Peng, Wei Wei, Qing Tian, Ying-Hua Liu, Fu-Yuan Cao, Qun Wang, Jian-Zhi Wan. Relationship of adult neurogenesis with tau phosphorylation and GSK-3β activity in subventricular zone. Neurochemical research. vol 36. issue 2. 2011-04-29. PMID:21061060. altered neurogenesis has been reported in alzheimer disease (ad), the most common neurodegenerative disorder characterized with hyperphosphorylated tau and accumulation of β-amyloid (aβ). 2011-04-29 2023-08-12 mouse
Anindita Bose, François Mouton-Liger, Claire Paquet, Pierre Mazot, Marc Vigny, Françoise Gray, Jacques Hugo. Modulation of tau phosphorylation by the kinase PKR: implications in Alzheimer's disease. Brain pathology (Zurich, Switzerland). vol 21. issue 2. 2011-04-28. PMID:21029237. modulation of tau phosphorylation by the kinase pkr: implications in alzheimer's disease. 2011-04-28 2023-08-12 Not clear
Tobias Bittner, Martin Fuhrmann, Steffen Burgold, Simon M Ochs, Nadine Hoffmann, Gerda Mitteregger, Hans Kretzschmar, Frank M LaFerla, Jochen Herm. Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice. PloS one. vol 5. issue 11. 2011-04-27. PMID:21103384. the pathology of alzheimer's disease (ad) is characterized by the accumulation of amyloid-β (aβ) peptide, hyperphosphorylated tau protein, neuronal death, and synaptic loss. 2011-04-27 2023-08-12 mouse
Claire Thornton, Nicola J Bright, Magdalena Sastre, Phillip J Muckett, David Carlin. AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid β-peptide exposure. The Biochemical journal. vol 434. issue 3. 2011-04-25. PMID:21204788. hyperphosphorylation of tau is a hallmark of alzheimer's disease and other tauopathies. 2011-04-25 2023-08-12 mouse
Anne Gauthier-Kemper, Carina Weissmann, Nataliya Golovyashkina, Zsofia Sebö-Lemke, Gerard Drewes, Volker Gerke, Jürgen J Heinisch, Roland Brand. The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner. The Journal of cell biology. vol 192. issue 4. 2011-04-25. PMID:21339331. changes of the microtubule-associated protein tau are central in alzheimer's disease (ad) and frontotemporal dementia with parkinsonism linked to chromosome 17 (ftdp-17). 2011-04-25 2023-08-12 Not clear
Anders M Fjell, Kristine B Walhovd, Christine Fennema-Notestine, Linda K McEvoy, Donald J Hagler, Dominic Holland, Kaj Blennow, James B Brewer, Anders M Dal. Brain atrophy in healthy aging is related to CSF levels of Aβ1-42. Cerebral cortex (New York, N.Y. : 1991). vol 20. issue 9. 2011-04-21. PMID:20051356. reduced levels of beta-amyloid(1-42) (abeta1-42) and increased levels of tau proteins in the cerebrospinal fluid (csf) are found in alzheimer's disease (ad), likely reflecting abeta deposition in plaques and neuronal and axonal damage. 2011-04-21 2023-08-12 Not clear
Xi Li, Ying Liu, Xin Zhang, Haifeng Yuan, Qiankun Qua. [Effect of ginsenoside Rg1 on expressions of phosphory protein tau and N-methyl-D-aspartate receptor subunits NR1 and NR2B in rat brain slice model of Alzheimer's disease]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. vol 35. issue 24. 2011-04-12. PMID:21438403. [effect of ginsenoside rg1 on expressions of phosphory protein tau and n-methyl-d-aspartate receptor subunits nr1 and nr2b in rat brain slice model of alzheimer's disease]. 2011-04-12 2023-08-12 rat
Xi Li, Ying Liu, Xin Zhang, Haifeng Yuan, Qiankun Qua. [Effect of ginsenoside Rg1 on expressions of phosphory protein tau and N-methyl-D-aspartate receptor subunits NR1 and NR2B in rat brain slice model of Alzheimer's disease]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. vol 35. issue 24. 2011-04-12. PMID:21438403. to investigate the effect of ginsenoside rg1 on the expressions of phosphory protein tau (p-tau), n-methyl-d-aspartate receptor subunit 1 (nr1) and n-methyl-d-aspartate receptor subunit 2b(nr2b) in rat brain slice model of alzheimer's disease. 2011-04-12 2023-08-12 rat
Mei Ning, Zhou Zhang, Zhuo Chen, Teng Zhao, Di Zhang, Daizhan Zhou, Weidong Li, Yun Liu, Yifeng Yang, Sheng Li, Lin H. Genetic evidence that vascular dementia is related to Alzheimer's disease: genetic association between tau polymorphism and vascular dementia in the Chinese population. Age and ageing. vol 40. issue 1. 2011-04-11. PMID:21044986. genetic evidence that vascular dementia is related to alzheimer's disease: genetic association between tau polymorphism and vascular dementia in the chinese population. 2011-04-11 2023-08-12 Not clear
Jane A Driver, Kun Ping L. Pin1: a new genetic link between Alzheimer's disease, cancer and aging. Current aging science. vol 3. issue 3. 2011-04-08. PMID:20735350. the loss of active pin1 leads to the accumulation of abnormal tau and the overproduction of β-amyloid, the cardinal features of alzheimer's disease. 2011-04-08 2023-08-12 mouse
Olivia A Shipton, Julie R Leitz, Jenny Dworzak, Christine E J Acton, Elizabeth M Tunbridge, Franziska Denk, Hana N Dawson, Michael P Vitek, Richard Wade-Martins, Ole Paulsen, Mariana Vargas-Caballer. Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 31. issue 5. 2011-04-01. PMID:21289177. amyloid β (aβ) and tau protein are both implicated in memory impairment, mild cognitive impairment (mci), and early alzheimer's disease (ad), but whether and how they interact is unknown. 2011-04-01 2023-08-12 mouse
Astrid Sydow, Ann Van der Jeugd, Fang Zheng, Tariq Ahmed, Detlef Balschun, Olga Petrova, Dagmar Drexler, Lepu Zhou, Gabriele Rune, Eckhard Mandelkow, Rudi D'Hooge, Christian Alzheimer, Eva-Maria Mandelko. Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 31. issue 7. 2011-04-01. PMID:21325519. only pro-aggregant mice show pronounced changes typical for tau pathology in alzheimer's disease (aggregation, missorting, hyperphosphorylation, synaptic and neuronal loss), indicating that the β-propensity and hence the ability to aggregate is a key factor in the disease. 2011-04-01 2023-08-12 mouse
Laurel Vana, Nicholas M Kanaan, Kevin Hakala, Susan T Weintraub, Lester I Binde. Peroxynitrite-induced nitrative and oxidative modifications alter tau filament formation. Biochemistry. vol 50. issue 7. 2011-03-31. PMID:21210655. tau undergoes numerous posttranslational modifications during the progression of alzheimer's disease (ad). 2011-03-31 2023-08-12 Not clear
Liana G Apostolova, Kristy S Hwang, John P Andrawis, Amity E Green, Sona Babakchanian, Jonathan H Morra, Jeffrey L Cummings, Arthur W Toga, John Q Trojanowski, Leslie M Shaw, Clifford R Jack, Ronald C Petersen, Paul S Aisen, William J Jagust, Robert A Koeppe, Chester A Mathis, Michael W Weiner, Paul M Thompso. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiology of aging. vol 31. issue 8. 2011-03-29. PMID:20538372. cerebrospinal fluid (csf) measures of ab and tau, pittsburgh compound b (pib) imaging and hippocampal atrophy are promising alzheimer's disease biomarkers yet the associations between them are not known. 2011-03-29 2023-08-12 human
A Caroli, G B Frison. The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort. Neurobiology of aging. vol 31. issue 8. 2011-03-29. PMID:20538373. the aim of this study was to investigate the dynamics of four of the most validated biomarkers for alzheimer's disease (ad), cerebro-spinal fluid (csf) abeta 1-42, tau, hippocampal volume, and fdg-pet, in patients at different stage of ad. 2011-03-29 2023-08-12 human
S K Madsen, A J Ho, X Hua, P S Saharan, A W Toga, C R Jack, M W Weiner, P M Thompso. 3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects. Neurobiology of aging. vol 31. issue 8. 2011-03-29. PMID:20538376. mri research examining structural brain atrophy in alzheimer's disease (ad) generally focuses on medial temporal and cortical structures, but amyloid and tau deposits also accumulate in the caudate. 2011-03-29 2023-08-12 human
Duygu Tosun, Norbert Schuff, Diana Truran-Sacrey, Leslie M Shaw, John Q Trojanowski, Paul Aisen, Ronald Peterson, Michael W Weine. Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study. Neurobiology of aging. vol 31. issue 8. 2011-03-29. PMID:20570401. previously it was reported that alzheimer's disease (ad) patients have reduced beta amyloid (abeta(1-42)) and elevated total tau (t-tau) and phosphorylated tau (p-tau(181p)) in the cerebrospinal fluid (csf), suggesting that these same measures could be used to detect early ad pathology in healthy elderly individuals and those with mild cognitive impairment (mci). 2011-03-29 2023-08-12 human
Theresa M Yuraszeck, Pierre Neveu, Maria Rodriguez-Fernandez, Anne Robinson, Kenneth S Kosik, Francis J Doyl. Vulnerabilities in the tau network and the role of ultrasensitive points in tau pathophysiology. PLoS computational biology. vol 6. issue 11. 2011-03-29. PMID:21085645. we used a systems biology approach to study tau aggregation, one of the hallmark features of alzheimer's disease. 2011-03-29 2023-08-12 Not clear